ArticleThe Journal of clinical investigation2023

Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling.

Ling Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.